{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:49:59Z","timestamp":1792601399632,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Extensive changes of circRNA expression underscore their essential contributions to multiple hallmarks of cancers; however, their functions and mechanisms of action in esophageal squamous cell carcinoma (ESCC) remain undetermined. Here, we adopted a three-stage approach by first screening for significantly differentially expressed circRNAs in ESCC and performing an external validation study, followed by the functional analyses. The properties of circRNAs were evaluated using Sanger sequencing, RNase R digestion, actinomycin D treatment, subcellular localization analysis, and fluorescence in situ hybridization. Target transcripts were predicted using online tools and verified by dual-luciferase, RNA immunoprecipitation, qRT-PCR, and western blot. Biotin-labeled RNA-protein pull-down, mass spectrometry, and RNA immunoprecipitation were employed to identify proteins interacting with circRNAs. Gain- and loss-of-function experiments were performed to uncover the roles of circRNAs, their target genes, and binding proteins in the proliferation, metastasis, and invasion. We observed that circFAM120B (hsa_circ_0001666) was frequently downregulated in cancer tissues and patient plasma, and its expression level was related to overall survival in ESCC patients. Overexpression of circFAM120B inhibited the proliferation, metastasis, and invasion of ESCC while silencing it enhanced malignant phenotypes. Mechanistically, circFAM120B was predominantly located in the cytoplasm, guarantying its sponging for miR-661 to restore the expression of PPM1L, a tumor suppressor. We observed that circFAM120B could reduce the stability of RNA-dependent protein kinase (PKR) by promoting its ubiquitination-dependent degradation and subsequently regulating the p38 MAPK signaling pathway, resulting in the repression of EMTs in ESCC cells. Our findings suggest that circFAM120B is a promising biomarker of ESCC, which acts as a tumor suppressor via the circFAM120B\/miR-661\/PPM1L axis and PKR\/p38 MAPK\/EMT pathway, supporting its significance as a candidate therapeutic target.<\/jats:p>","DOI":"10.1038\/s41419-022-04818-5","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T13:02:58Z","timestamp":1650286978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["circFAM120B functions as a tumor suppressor in esophageal squamous cell carcinoma via the miR-661\/PPM1L axis and the PKR\/p38 MAPK\/EMT pathway"],"prefix":"10.1038","volume":"13","author":[{"given":"Huan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9151-284X","authenticated-orcid":false,"given":"Jianming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"4818_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"4818_CR2","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41422-020-0333-6","volume":"30","author":"Y Cui","year":"2020","unstructured":"Cui Y, Chen H, Xi R, Cui H, Zhao Y, Xu E, et al. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma. Cell Res. 2020;30:902\u201313. https:\/\/doi.org\/10.1038\/s41422-020-0333-6.","journal-title":"Cell Res"},{"key":"4818_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/gutjnl-2020-321089","volume":"70","author":"E Morgan","year":"2021","unstructured":"Morgan E, Soerjomataram I, Gavin AT, Rutherford MJ, Gatenby P, Bardot A, et al. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 2021;70:234\u201342. https:\/\/doi.org\/10.1136\/gutjnl-2020-321089.","journal-title":"Gut"},{"key":"4818_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023\u201375. https:\/\/doi.org\/10.1016\/s0140-6736(17)33326-3.","journal-title":"Lancet"},{"key":"4818_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.7326\/m17-2000","volume":"168","author":"C Yu","year":"2018","unstructured":"Yu C, Tang H, Guo Y, Bian Z, Yang L, Chen Y, et al. Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study. Ann Intern Med. 2018;168:489\u201397. https:\/\/doi.org\/10.7326\/m17-2000.","journal-title":"Ann Intern Med"},{"key":"4818_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ng.2935","volume":"46","author":"DC Lin","year":"2014","unstructured":"Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet. 2014;46:467\u201373. https:\/\/doi.org\/10.1038\/ng.2935.","journal-title":"Nat Genet"},{"key":"4818_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1041-z","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang W, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019;18:116. https:\/\/doi.org\/10.1186\/s12943-019-1041-z.","journal-title":"Mol Cancer"},{"key":"4818_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391. https:\/\/doi.org\/10.1038\/s41576-019-0158-7.","journal-title":"Nat Rev Genet"},{"key":"4818_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01221-6","volume":"19","author":"N Zhang","year":"2020","unstructured":"Zhang N, Nan A, Chen L, Li X, Jia Y, Qiu M, et al. Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells. Mol Cancer. 2020;19:101. https:\/\/doi.org\/10.1186\/s12943-020-01221-6.","journal-title":"Mol Cancer"},{"key":"4818_CR10","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.2147\/CMAR.S167863","volume":"10","author":"P Shi","year":"2018","unstructured":"Shi P, Sun J, He B, Song H, Li Z, Kong W, et al. Profiles of differentially expressed circRNAs in esophageal and breast cancer. Cancer Manag Res. 2018;10:2207\u201321. https:\/\/doi.org\/10.2147\/CMAR.S167863.","journal-title":"Cancer Manag Res"},{"key":"4818_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/ejhf.801","volume":"19","author":"Y Devaux","year":"2017","unstructured":"Devaux Y, Creemers EE, Boon RA, Werfel S, Thum T, Engelhardt S, et al. Circular RNAs in heart failure. Eur J Heart Fail. 2017;19:701\u20139. https:\/\/doi.org\/10.1002\/ejhf.801.","journal-title":"Eur J Heart Fail"},{"key":"4818_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41569-019-0185-2","volume":"16","author":"S Aufiero","year":"2019","unstructured":"Aufiero S, Reckman YJ, Pinto YM, Creemers EE. Circular RNAs open a new chapter in cardiovascular biology. Nat Rev Cardiol. 2019;16:503\u201314. https:\/\/doi.org\/10.1038\/s41569-019-0185-2.","journal-title":"Nat Rev Cardiol"},{"key":"4818_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2017.02.021","volume":"66","author":"NR Pamudurti","year":"2017","unstructured":"Pamudurti NR, Bartok O, Jens M, Ashwal-Fluss R, Stottmeister C, Ruhe L, et al. Translation of CircRNAs. Mol Cell. 2017;66:9\u201321.e27. https:\/\/doi.org\/10.1016\/j.molcel.2017.02.021.","journal-title":"Mol Cell"},{"key":"4818_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.120.049715","volume":"143","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, Xia L, Fan S, Zheng J, Qin J, Fan X, et al. Circular RNA CircMAP3K5 acts as a microRNA-22-3p sponge to promote resolution of intimal hyperplasia via TET2-mediated smooth muscle cell differentiation. Circulation. 2021;143:354\u201371. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.049715.","journal-title":"Circulation"},{"key":"4818_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384\u20138. https:\/\/doi.org\/10.1038\/nature11993.","journal-title":"Nature"},{"key":"4818_CR16","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-16-2541","volume":"23","author":"W Weng","year":"2017","unstructured":"Weng W, Wei Q, Toden S, Yoshida K, Nagasaka T, Fujiwara T, et al. Circular RNA ciRS-7-A promising prognostic biomarker and a potential therapeutic target in colorectal cancer. Clin Cancer Res. 2017;23:3918\u201328. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2541.","journal-title":"Clin Cancer Res"},{"key":"4818_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0852-y","volume":"9","author":"RC Li","year":"2018","unstructured":"Li RC, Ke S, Meng FK, Lu J, Zou XJ, He ZG, et al. CiRS-7 promotes growth and metastasis of esophageal squamous cell carcinoma via regulation of miR-7\/HOXB13. Cell Death Dis. 2018;9:838 https:\/\/doi.org\/10.1038\/s41419-018-0852-y.","journal-title":"Cell Death Dis"},{"key":"4818_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1094-z","volume":"18","author":"F Yang","year":"2019","unstructured":"Yang F, Hu A, Li D, Wang J, Guo Y, Liu Y, et al. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer. 2019;18:158. https:\/\/doi.org\/10.1186\/s12943-019-1094-z.","journal-title":"Mol Cancer"},{"key":"4818_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01269-4","volume":"19","author":"S Shen","year":"2020","unstructured":"Shen S, Yao T, Xu Y, Zhang D, Fan S, Ma J. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol Cancer. 2020;19:151. https:\/\/doi.org\/10.1186\/s12943-020-01269-4.","journal-title":"Mol Cancer"},{"key":"4818_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10138-8","volume":"10","author":"C Darini","year":"2019","unstructured":"Darini C, Ghaddar N, Chabot C, Assaker G, Sabri S, Wang S, et al. An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy. Nat Commun. 2019;10:2139. https:\/\/doi.org\/10.1038\/s41467-019-10138-8.","journal-title":"Nat Commun"},{"key":"4818_CR21","doi-asserted-by":"publisher","first-page":"e1558.","DOI":"10.1002\/wrna.1558","volume":"11","author":"YS Lee","year":"2020","unstructured":"Lee YS, Kunkeaw N, Lee YS. Protein kinase R and its cellular regulators in cancer: An active player or a surveillant? Wiley Interdiscip Rev RNA. 2020;11:e1558. https:\/\/doi.org\/10.1002\/wrna.1558.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"4818_CR22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1182\/blood-2015-03-635227","volume":"126","author":"X Cheng","year":"2015","unstructured":"Cheng X, Byrne M, Brown KD, Konopleva MY, Kornblau SM, Bennett RL, et al. PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice. Blood. 2015;126:1585\u201394. https:\/\/doi.org\/10.1182\/blood-2015-03-635227.","journal-title":"Blood"},{"key":"4818_CR23","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1093\/emboj\/19.16.4292","volume":"19","author":"KC Goh","year":"2000","unstructured":"Goh KC, deVeer MJ, Williams BR. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 2000;19:4292\u20137. https:\/\/doi.org\/10.1093\/emboj\/19.16.4292.","journal-title":"EMBO J"},{"key":"4818_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-1-4939-7562-4_17","volume":"1724","author":"Y Li","year":"2018","unstructured":"Li Y, Chen B, Huang S. Identification of circRNAs for miRNA targets by argonaute2 RNA immunoprecipitation and luciferase screening assays. Methods Mol Biol. 2018;1724:209\u201318. https:\/\/doi.org\/10.1007\/978-1-4939-7562-4_17.","journal-title":"Methods Mol Biol"},{"key":"4818_CR25","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/sj.onc.1209906","volume":"26","author":"Y Takada","year":"2007","unstructured":"Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44\/p42 MAPK and p38 MAPK activation. Oncogene. 2007;26:1201\u201312. https:\/\/doi.org\/10.1038\/sj.onc.1209906.","journal-title":"Oncogene"},{"key":"4818_CR26","doi-asserted-by":"publisher","first-page":"eaay1486.","DOI":"10.1126\/scisignal.aay1486","volume":"13","author":"LS Richardson","year":"2020","unstructured":"Richardson LS, Taylor RN, Menon R. Reversible EMT and MET mediate amnion remodeling during pregnancy and labor. Sci Signal. 2020;13:eaay1486. https:\/\/doi.org\/10.1126\/scisignal.aay1486.","journal-title":"Sci Signal"},{"key":"4818_CR27","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1101\/gr.135350.111","volume":"22","author":"J Harrow","year":"2012","unstructured":"Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 2012;22:1760\u201374. https:\/\/doi.org\/10.1101\/gr.135350.111.","journal-title":"Genome Res"},{"key":"4818_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2014.08.018","volume":"159","author":"JM Engreitz","year":"2014","unstructured":"Engreitz JM, Sirokman K, McDonel P, Shishkin AA, Surka C, Russell P, et al. RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites. Cell. 2014;159:188\u201399. https:\/\/doi.org\/10.1016\/j.cell.2014.08.018.","journal-title":"Cell"},{"key":"4818_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/jnci\/djx166","volume":"110","author":"Y Yang","year":"2018","unstructured":"Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao F, et al. Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis. J Natl Cancer Inst. 2018;110:304\u201315. https:\/\/doi.org\/10.1093\/jnci\/djx166.","journal-title":"J Natl Cancer Inst"},{"key":"4818_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1134-8","volume":"19","author":"X Jian","year":"2020","unstructured":"Jian X, He H, Zhu J, Zhang Q, Zheng Z, Liang X, et al. Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340. Mol Cancer. 2020;19:20. https:\/\/doi.org\/10.1186\/s12943-020-1134-8.","journal-title":"Mol Cancer"},{"key":"4818_CR31","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/nar\/gkv1367","volume":"44","author":"Y Enuka","year":"2016","unstructured":"Enuka Y, Lauriola M, Feldman ME, Sas-Chen A, Ulitsky I, Yarden Y. Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor. Nucleic Acids Res. 2016;44:1370\u201383. https:\/\/doi.org\/10.1093\/nar\/gkv1367.","journal-title":"Nucleic Acids Res"},{"key":"4818_CR32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","volume":"58","author":"A Rybak-Wolf","year":"2015","unstructured":"Rybak-Wolf A, Stottmeister C, Glazar P, Jens M, Pino N, Giusti S, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58:870\u201385. https:\/\/doi.org\/10.1016\/j.molcel.2015.03.027.","journal-title":"Mol Cell"},{"key":"4818_CR33","doi-asserted-by":"publisher","first-page":"e10168.","DOI":"10.15252\/emmm.201810168","volume":"11","author":"HQ Ju","year":"2019","unstructured":"Ju HQ, Zhao Q, Wang F, Lan P, Wang Z, Zuo ZX, et al. A circRNA signature predicts postoperative recurrence in stage II\/III colon cancer. EMBO Mol Med. 2019;11:e10168. https:\/\/doi.org\/10.15252\/emmm.201810168.","journal-title":"EMBO Mol Med"},{"key":"4818_CR34","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.tibs.2020.08.006","volume":"45","author":"L Yan","year":"2020","unstructured":"Yan L, Chen YG. Circular RNAs in immune response and viral infection. Trends Biochem Sci. 2020;45:1022\u201334. https:\/\/doi.org\/10.1016\/j.tibs.2020.08.006.","journal-title":"Trends Biochem Sci"},{"key":"4818_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0698-4","volume":"16","author":"F Liu","year":"2017","unstructured":"Liu F, Cai Y, Rong X, Chen J, Zheng D, Chen L, et al. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer. Mol Cancer. 2017;16:122. https:\/\/doi.org\/10.1186\/s12943-017-0698-4.","journal-title":"Mol Cancer"},{"key":"4818_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12:295. https:\/\/doi.org\/10.1038\/s41467-020-20527-z.","journal-title":"Nat Commun"},{"key":"4818_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.biopha.2015.07.023","volume":"75","author":"T Zhu","year":"2015","unstructured":"Zhu T, Yuan J, Wang Y, Gong C, Xie Y, Li H. MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression. Biomed Pharmacother. 2015;75:123\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2015.07.023.","journal-title":"Biomed Pharmacother"},{"key":"4818_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002.","journal-title":"Cell"},{"key":"4818_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/gcc.20724","volume":"49","author":"LF Thean","year":"2010","unstructured":"Thean LF, Loi C, Ho KS, Koh PK, Eu KW, Cheah PY. Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients. Genes Chromosomes Cancer. 2010;49:99\u2013106. https:\/\/doi.org\/10.1002\/gcc.20724.","journal-title":"Genes Chromosomes Cancer"},{"key":"4818_CR40","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3892\/ol.2014.2560","volume":"8","author":"X Wang","year":"2014","unstructured":"Wang X, Dong JH, Zhang WZ, Leng JJ, Cai SW, Chen MY, et al. Double stranded RNA-dependent protein kinase promotes the tumorigenic phenotype in HepG2 hepatocellular carcinoma cells by activating STAT3. Oncol Lett. 2014;8:2762\u20138. https:\/\/doi.org\/10.3892\/ol.2014.2560.","journal-title":"Oncol Lett"},{"key":"4818_CR41","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1128\/jvi.00016-16","volume":"90","author":"M Kainulainen","year":"2016","unstructured":"Kainulainen M, Lau S, Samuel CE, Hornung V, Weber F. NSs virulence factor of rift valley fever virus engages the F-box proteins FBXW11 and \u03b2-TRCP1 to degrade the antiviral protein kinase PKR. J Virol. 2016;90:6140\u20137. https:\/\/doi.org\/10.1128\/jvi.00016-16.","journal-title":"J Virol"},{"key":"4818_CR42","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1245\/s10434-019-08043-x","volume":"27","author":"WC Chiu","year":"2020","unstructured":"Chiu WC, Fang PT, Lee YC, Wang YY, Su YH, Hu SC, et al. DNA repair protein Rad51 induces tumor growth and metastasis in esophageal squamous cell carcinoma via a p38\/Akt-dependent pathway. Ann Surg Oncol. 2020;27:2090\u2013101. https:\/\/doi.org\/10.1245\/s10434-019-08043-x.","journal-title":"Ann Surg Oncol"},{"key":"4818_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","volume":"442","author":"S Wen","year":"2019","unstructured":"Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M, et al. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23-p38 MAPK signalling. Cancer Lett. 2019;442:320\u201332. https:\/\/doi.org\/10.1016\/j.canlet.2018.10.015.","journal-title":"Cancer Lett"},{"key":"4818_CR44","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41401-020-00596-y","volume":"42","author":"N Zhu","year":"2021","unstructured":"Zhu N, Zhang XJ, Zou H, Zhang YY, Xia JW, Zhang P, et al. PTPL1 suppresses lung cancer cell migration via inhibiting TGF-\u03b21-induced activation of p38 MAPK and Smad 2\/3 pathways and EMT. Acta Pharm Sin. 2021;42:1280\u20137. https:\/\/doi.org\/10.1038\/s41401-020-00596-y.","journal-title":"Acta Pharm Sin"},{"key":"4818_CR45","doi-asserted-by":"publisher","first-page":"53459","DOI":"10.18632\/oncotarget.10557","volume":"7","author":"X Yuan","year":"2016","unstructured":"Yuan X, Wang W, Li J, Zheng P, Dong P, Chen L, et al. Gelsolin suppresses gastric cancer metastasis through inhibition of PKR-p38 signaling. Oncotarget. 2016;7:53459\u201370. https:\/\/doi.org\/10.18632\/oncotarget.10557.","journal-title":"Oncotarget"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04818-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04818-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04818-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:04:33Z","timestamp":1669302273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04818-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["4818"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04818-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"4 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the ethics committee of Nanjing Medical University (Nanjing, Jiangsu, China). All participants provided informed consent to supply materials for this study. This study was carried out in accordance with the provisions of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"361"}}